Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Clopidogrel response variability and the advent of personalised antiplatelet therapy. A bench to bedside journey.
Gurbel PA, Tantry US.
Thromb Haemost. 2011 Aug;106(2):265-71. Epub 2011 Jun 28. Review.
Related citations
Peri-operative platelet function testing: the potential for reducing ischaemic and bleeding risks.
Gurbel PA, Mahla E, Tantry US.
Thromb Haemost. 2011 Aug;106(2):248-52. Epub 2011 Apr 20. Review.
High platelet reactivity and clinical outcome - fact and fiction.
Sibbing D, Byrne RA, Bernlochner I, Kastrati A.
Thromb Haemost. 2011 Aug;106(2):191-202. Epub 2011 Apr 20. Review.
Massive thrombus burden with recurrence of intracoronary thrombosis early after stenting and delayed onset of prasugrel action in a patient with ST-elevation myocardial infarction and cardiac shock.
Orban M, Byrne RA, Hausleiter J, Laugwitz KL, Sibbing D.
Thromb Haemost. 2011 Sep;106(3):555-8. Epub 2011 Jul 4. No abstract available.
Platelet factor XIII gene expression and embolic propensity in atrial fibrillation.
Gosk-Bierska I, McBane RD, Wu Y, Mruk J, Tafur A, McLeod T, Wysokinski WE.
Thromb Haemost. 2011 Jul;106(1):75-82. Epub 2011 Jun 9.
Is increased platelet turnover responsible for low responsiveness to different thienopyridienes? A case report of recurrent stent thromboses.
Freynhofer MK, Bruno V, Brozovic I, Grove EL, Kristensen SD, Willheim M, Hübl W, Huber K.
Thromb Haemost. 2011 Jul;106(1):182-4. Epub 2011 May 5. No abstract available.
The relationship between platelet reactivity and infarct-related artery patency in patients presenting with a ST-elevation myocardial infarction.
Breet NJ, van Werkum JW, Bouman HJ, Kelder JC, Hackeng CM, ten Berg JM.
Thromb Haemost. 2011 Aug;106(2):331-6. Epub 2011 Jun 28.
The in vitro effect of the new antithrombotic drug candidate ALX-0081 on blood samples of patients undergoing percutaneous coronary intervention.
van Loon JE, de Jaegere PP, Ulrichts H, van Vliet HH, de Maat MP, de Groot PG, Simoons ML, Leebeek FW.
Thromb Haemost. 2011 Jul;106(1):165-71. Epub 2011 Jun 9.
Proton pump inhibitors, genetic polymorphisms and response to clopidogrel therapy.
Fernando H, Dart AM, Peter K, Shaw JA.
Thromb Haemost. 2011 Jun;105(6):933-44. Epub 2011 May 5. Review.
Warfarin treatment outcomes in children monitored at home with a point-of-care device.
Biss T, Avery PJ, Walsh PM, Kamali F.
Thromb Haemost. 2011 Jun;105(6):1103-5. Epub 2011 Mar 24. No abstract available.
Multiple electrode aggregometry and vasodilator stimulated phosphoprotein-phosphorylation assay in clinical routine for prediction of postprocedural major adverse cardiovascular events.
Freynhofer MK, Brozovic I, Bruno V, Farhan S, Vogel B, Jakl G, Willheim M, Hübl W, Wojta J, Huber K.
Thromb Haemost. 2011 Aug;106(2):230-9. Epub 2011 May 26.
High residual platelet reactivity on standard clopidogrel maintenance dose predicts increased responsiveness to the double-standard dose in an assay-dependent manner.
Oestreich JH, Steinhubl SR, Ferraris SP, Akers WS.
Thromb Haemost. 2011 May;105(5):927-30. Epub 2011 Mar 24. No abstract available.
High soluble Fas and soluble Fas Ligand serum levels before stent implantation are protective against restenosis.
Katsaros KM, Wiesbauer F, Speidl WS, Kastl SP, Huber K, Zorn G, Niessner A, Glogar D, Maurer G, Wojta J.
Thromb Haemost. 2011 May;105(5):883-91. Epub 2011 Feb 28.
Comparative assessment of drug-eluting balloons in an advanced porcine model of coronary restenosis.
Joner M, Byrne RA, Lapointe JM, Radke PW, Bayer G, Steigerwald K, Wittchow E.
Thromb Haemost. 2011 May;105(5):864-72. Epub 2011 Feb 8.
Clopidogrel withdrawal: is there a "rebound" phenomenon?
Sambu N, Warner T, Curzen N.
Thromb Haemost. 2011 Feb;105(2):211-20. Epub 2010 Nov 23. Review.
High-shear- and-thrombin-inducible platelet adhesion and aggregation in patients undergoing percutaneous coronary intervention. Effects of unfractionated heparin versus bivalirudin.
Eslam RB, Reiter N, Kaider A, Lang IM, Panzer S.
Thromb Haemost. 2011 Mar;105(3):496-500. Epub 2010 Dec 21.
The role of fibrinolysis in the era of primary percutaneous coronary intervention.
Halvorsen S, Huber K.
Thromb Haemost. 2011 Mar;105(3):390-5. Epub 2010 Dec 6. No abstract available.
Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment.
Bernlochner I, Steinhubl S, Braun S, Morath T, Jaitner J, Stegherr J, Mehilli J, von Beckerath N, Schömig A, Kastrati A, Sibbing D.
Thromb Haemost. 2010 Dec;104(6):1193-200. Epub 2010 Sep 13.
Target vessel reopening by guidewire insertion in ST-elevation myocardial infarction is a predictor of final TIMI flow and survival.
Adlbrecht C, Distelmaier K, Gündüz D, Redwan B, Plass C, Bonderman D, Kaider A, Christ G, Lang IM.
Thromb Haemost. 2011 Jan;105(1):52-8. Epub 2010 Nov 23.
Effects of aspirin and desmopressin on platelet reactivity in patients undergoing cardiac surgery with extracorporeal circulation.
Keyl C, Kmitta E, Kueri S, Zietak T, Trenk D.
Thromb Haemost. 2011 Jan;105(1):113-21. Epub 2010 Nov 5.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on